|
|
Volumn 6, Issue 21, 2015, Pages 18244-18245
|
|
Targeting interleukin-17 receptors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERLEUKIN 17 RECEPTOR;
INTERLEUKIN 17 RECEPTOR A;
INTERLEUKIN 17 RECEPTOR B;
INTERLEUKIN 17 RECEPTOR C;
INTERLEUKIN 17 RECEPTOR D;
INTERLEUKIN 17 RECEPTOR E;
INTERLEUKIN 17C;
INTERLEUKIN 25;
INTERLEUKIN 27;
UNCLASSIFIED DRUG;
INTERLEUKIN 17;
MONOCLONAL ANTIBODY;
CANCER GROWTH;
CANCER SURVIVAL;
DISEASE ASSOCIATION;
EDITORIAL;
HUMAN;
NONHUMAN;
PANCREAS CANCER;
PROGRESSION FREE SURVIVAL;
PROTEIN EXPRESSION;
PROTEIN INTERACTION;
PROTEIN TARGETING;
SEQUENCE HOMOLOGY;
SIGNAL TRANSDUCTION;
TUMOR MICROENVIRONMENT;
TUMOR PROMOTION;
ANIMAL;
BIOLOGICAL MODEL;
DRUG EFFECTS;
IMMUNOLOGY;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PANCREATIC NEOPLASMS;
PROCEDURES;
ANIMALS;
ANTIBODIES, MONOCLONAL;
HUMANS;
INTERLEUKIN-17;
MODELS, IMMUNOLOGICAL;
MOLECULAR TARGETED THERAPY;
PANCREATIC NEOPLASMS;
RECEPTORS, INTERLEUKIN-17;
SIGNAL TRANSDUCTION;
|
|
EID: 84938796817
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.4892 Document Type: Editorial |
|
Times cited : (7)
|
|
References (7)
|
